Wealth Enhancement Advisory Services
BMRN icon

Wealth Enhancement Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.64M Buy
112,375
+28,572
+34% +$1.67M 0.01% 847
2025
Q4 		$5.05M Sell
83,803
-5,621
-6% -$306K 0.01% 1015
2025
Q3 		$4.89M Buy
89,424
+15,043
+20% +$860K 0.01% 959
2025
Q2 		$4.28M Buy
74,381
+29,797
+67% +$1.75M 0.01% 966
2025
Q1 		$3.15M Buy
44,584
+21,383
+92% +$1.44M 0.01% 1026
2024
Q4 		$1.53M Buy
23,201
+17,340
+296% +$1.16M ﹤0.01% 1314
2024
Q3 		$412K Buy
5,861
+2,289
+64% +$191K ﹤0.01% 1958
2024
Q2 		$294K Buy
+3,572
New +$297K ﹤0.01% 1994

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return